Skip Navigation


The Brady Urological Institute at Johns Hopkins

Physicians with The Brady Urological Institute at Johns Hopkins—consistently ranked by U.S. News & World Report as having among the top urology programs in the country—have been pioneers in their field and were the first to perform landmark operations such as:

  • Radical prostatectomy
  • Nerve-sparing radical retropubic prostatectomy
  • Minimally invasive live donor kidney removal

Our doctors are dedicated to providing state-of-the-art medical and surgical care in all aspects of adult and pediatric urology. Hopkins urologists have extensive expertise in surgical techniques including:

  • Open and minimally invasive radical prostatectomy
  • Urologic reconstruction
  • Laparoscopy
  • Treatment of rare stone disease
  • Treatment for benign prostate hypertrophy
  • Treatment of erectile dysfunction
  • Microsurgery for infertility
  • Vasectomy reversal
  • Minimally invasive techniques to treat kidney disease
  • Treatment of urinary incontinence
  • Hypospadius reconstruction
  • Bladder exstrophy reconstruction

Prostate and Other Urologic Cancers

The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins has a strong program in prostate cancer diagnosis, staging and treatment. World-renowned pathologists here can identify cancer cells at a much earlier stage of diagnosis, ensuring the best outcomes. Surgeons and oncologists work together to develop the best course of treatment.

With the radical prostatectomy or nerve-sparing surgery developed at Johns Hopkins, 50 to 70 percent of patients retain their potency and 93 percent their continence.

Urologic cancers our team excels in treating include:

  • Prostate
  • Bladder
  • Kidney
  • Testes
  • Penile
  • Adrenal

To learn more or to make an appointment, call+1-410-502-7683.

Discover Our Research

"Theranostic' Imaging Offers Means of Killing Prostate Cancer Cells Without Harming Other Healthy Cells
Experimenting with human prostate cancer cells and mice, cancer imaging experts at Johns Hopkins say they have developed a method for finding and killing malignant cells while sparing healthy ones. Learn more.

Johns Hopkins Researchers Discover Link Between A Protein And Aggressive, Recurring Prostate Cancer
In a study to decipher clues about how prostate cancer cells grow and become more aggressive, Johns Hopkins urologists have found that reduction of a specific protein is correlated with the aggressiveness of prostate cancer, acting as a red flag to indicate an increased risk of cancer recurrence. Learn more about this study.

back to top button